Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
Public ClinicalTrials.gov record NCT00394199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Active-controlled, Parallel Group, Stratified, Multi-center, 12-week Study Comparing the Safety & Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm) 100/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Fluticasone (100 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent & Adult Patients With Mild to Moderate Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the efficacy and safety of the fixed combination asthma drug Flutiform HFA MDI with its two components administered alone, fluticasone propionate and formoterol fumarate, in adult and adolescent patients with mild to moderate asthma.
Study identification
- NCT ID
- NCT00394199
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 357 participants
Conditions and interventions
Conditions
Interventions
- Fluticasone propionate/Formoterol Fumarate 100/10 Drug
- Fluticasone propionate 100 Drug
- Formoterol fumarate 10 Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Jan 31, 2008
- Completion
- Jan 31, 2008
- Last update posted
- Jun 22, 2011
2006 – 2008
United States locations
- U.S. sites
- 29
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35242 | — |
| Research Site | Mission Viejo | California | 92691 | — |
| Research Site | Orange | California | 92868 | — |
| Research Site | San Jose | California | 95117 | — |
| Research Site | Vista | California | 92083 | — |
| Research Site | Denver | Colorado | 80230 | — |
| Research Site | Lilburn | Georgia | 30047 | — |
| Research Site | Savannah | Georgia | 31406 | — |
| Research Site | Park City | Kansas | 67219 | — |
| Research Site | Bethesda | Maryland | 20814 | — |
| Research Site | North Dartmouth | Massachusetts | 02747 | — |
| Research Center | Stevensville | Michigan | 49127 | — |
| Research Site | Elizabeth | New Jersey | 07202 | — |
| Research Center | Rochester | New York | 14618 | — |
| Research Site | Asheville | North Carolina | 28801 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Research Site | Sylvania | Ohio | 43560 | — |
| Research Site | Easton | Pennsylvania | 18045 | — |
| Research Site | Lincoln | Rhode Island | 02906 | — |
| Research Site | Greenville | South Carolina | 29605 | — |
| Research Site | Chattanooga | Tennessee | 37421 | — |
| Research Site | El Paso | Texas | 79902 | — |
| Research Site | Houston | Texas | 77054 | — |
| Research Site | Katy | Texas | 77450 | — |
| Research Site | New Braunfels | Texas | 78130 | — |
| Research Site | Waco | Texas | 76712 | — |
| Research Site | South Burlington | Vermont | 05403 | — |
| Research Site | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00394199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2011 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00394199 live on ClinicalTrials.gov.